Clinical Trial Update: A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial update of molidustat for renal anemia in peritoneal dialysis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Anemia

Drugs mentioned

• Molidustat (molidustat)

Snippet

Sponsor: Bayer | Conditions: Anemia, Renal Insufficiency, Chronic | Phase 3 | Status: COMPLETED